Legis Daily

End Taxpayer Subsidies for Drug Ads Act

USA116th CongressS-73| Senate 
| Updated: 1/10/2019
Jeanne Shaheen

Jeanne Shaheen

Democratic Senator

New Hampshire

Cosponsors (22)
Mazie K. Hirono (Democratic)Margaret Wood Hassan (Democratic)Dianne Feinstein (Democratic)Patrick J. Leahy (Democratic)Richard J. Durbin (Democratic)Jack Reed (Democratic)Kirsten E. Gillibrand (Democratic)Elizabeth Warren (Democratic)Kamala D. Harris (Democratic)Angus S. King (Independent)Amy Klobuchar (Democratic)Tim Kaine (Democratic)Sheldon Whitehouse (Democratic)Joe Manchin (Independent)Chris Van Hollen (Democratic)Michael F. Bennet (Democratic)Tina Smith (Democratic)Sherrod Brown (Democratic)Bernard Sanders (Independent)Brian Schatz (Democratic)Tammy Baldwin (Democratic)Richard Blumenthal (Democratic)

Finance Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
End Taxpayer Subsidies for Drug Ads Act This bill prohibits tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs. "Direct-to-consumer advertising" is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is (1) in regard to the drug product, and (2) primarily targeted to the general public.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 10, 2019
Introduced in Senate
Jan 10, 2019
Read twice and referred to the Committee on Finance.
Sep 25, 2020

Latest Companion Bill Action

HR 116-8399
Introduced in House
  • January 10, 2019
    Introduced in Senate


  • January 10, 2019
    Read twice and referred to the Committee on Finance.


  • September 25, 2020

    Latest Companion Bill Action

    HR 116-8399
    Introduced in House

Taxation

Related Bills

  • S 116-1801: Affordable Medications Act
  • HR 116-8399: End Taxpayer Subsidies for Drug Ads Act
Business expensesIncome tax deductionsMarketing and advertisingPrescription drugs

End Taxpayer Subsidies for Drug Ads Act

USA116th CongressS-73| Senate 
| Updated: 1/10/2019
End Taxpayer Subsidies for Drug Ads Act This bill prohibits tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs. "Direct-to-consumer advertising" is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is (1) in regard to the drug product, and (2) primarily targeted to the general public.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 10, 2019
Introduced in Senate
Jan 10, 2019
Read twice and referred to the Committee on Finance.
Sep 25, 2020

Latest Companion Bill Action

HR 116-8399
Introduced in House
  • January 10, 2019
    Introduced in Senate


  • January 10, 2019
    Read twice and referred to the Committee on Finance.


  • September 25, 2020

    Latest Companion Bill Action

    HR 116-8399
    Introduced in House
Jeanne Shaheen

Jeanne Shaheen

Democratic Senator

New Hampshire

Cosponsors (22)
Mazie K. Hirono (Democratic)Margaret Wood Hassan (Democratic)Dianne Feinstein (Democratic)Patrick J. Leahy (Democratic)Richard J. Durbin (Democratic)Jack Reed (Democratic)Kirsten E. Gillibrand (Democratic)Elizabeth Warren (Democratic)Kamala D. Harris (Democratic)Angus S. King (Independent)Amy Klobuchar (Democratic)Tim Kaine (Democratic)Sheldon Whitehouse (Democratic)Joe Manchin (Independent)Chris Van Hollen (Democratic)Michael F. Bennet (Democratic)Tina Smith (Democratic)Sherrod Brown (Democratic)Bernard Sanders (Independent)Brian Schatz (Democratic)Tammy Baldwin (Democratic)Richard Blumenthal (Democratic)

Finance Committee

Taxation

Related Bills

  • S 116-1801: Affordable Medications Act
  • HR 116-8399: End Taxpayer Subsidies for Drug Ads Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Business expensesIncome tax deductionsMarketing and advertisingPrescription drugs